Sclerosis multiplex (SM): vizsgálatok itt: Svédország
11 of 16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 16.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in SvédországA Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Where
- Huddinge, Stockholm, Stockholm
- Életkor
- 18 év to 60 év
- People
- 990 worldwide
- Run by
- Zenas BioPharma (USA), LLC
See details and how to joinNCT07299019 · EU 2025-524322-18-00 - 3. fázisTaking peopleA Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Where
- Huddinge
- Életkor
- 18 év to 60 év
- People
- 705 worldwide
- Run by
- Zenas BioPharma (USA), LLC
See details and how to joinNCT07067463 · EU 2025-524316-11-00 - 2. fázisTaking peopleThe HIt HArd and hiT Early in Multiple Sclerosis Trial
- Where
- Falun, Gavle, Karlstad, Uppsala
- Életkor
- 18 év to 50 év
- People
- 60
- Run by
- Uppsala University
See details and how to joinNCT07517185 · EU 2024-519700-28-01 - 3. fázisFut, nem toborozA Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis
- Where
- Goteborg
- Életkor
- 18 év to 64 év
- People
- 125 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-512914-16-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Where
- Gothenburg, Stockholm
- Életkor
- 18 év to 65 év
- People
- 1275 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07225504 - 3. fázisNot yet taking people in SvédországNon-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Where
- Goteborg, Huddinge, Malmo, Stockholm
- Életkor
- 18 év to 60 év
- People
- 160 worldwide
- Run by
- Sanofi
See details and how to joinNCT07325292 · EU 2026-525688-41-00 - 3. fázisTaking peopleA clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
- Where
- Goteborg, Huddinge
- Életkor
- 18 év and over
- People
- 677 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-521546-23-00 - 3. fázisTaking peopleA Randomized Open Label Trial Exploring the Soluble and Imaging Biomarker Dynamic Responses to Tolebrutinib Compared to Rituximab Treatment in Patients with Multiple Sclerosis (MS)
- Where
- Stockholm
- Életkor
- 18 év and over
- People
- 60
- Run by
- Region Stockholm – SLSO
See details and how to join2025-523892-50-00 - No phaseNot yet taking people in SvédországEvaluation of the Wheelchair School (Drivkraft) a Clinical Study
- Where
- Solna
- Életkor
- 18 év and over
- People
- 80
- Run by
- Karolinska Institutet
See details and how to joinNCT07131553 - No phaseTaking peopleMotor-cognitive Performance in People With Multiple Sclerosis
- Where
- Stockholm
- Életkor
- 18 év to 65 év
- People
- 90
- Run by
- Karolinska Institutet
See details and how to joinNCT06312046 - No phaseCsak meghívásosInternet Delivered Cognitive Rehabilitation for Mild Cognitive Impairments
- Where
- Stockholm
- Életkor
- 18 év and over
- People
- 64
- Run by
- Aniko Bartfai
See details and how to joinNCT06973018